Found: 33
Select item for more details and to access through your institution.
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 757, doi. 10.1007/s00432-014-1623-5
- By:
- Publication type:
- Article
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 4, p. 956, doi. 10.1002/eji.202048966
- By:
- Publication type:
- Article
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 11, p. 1810, doi. 10.1002/eji.202048534
- By:
- Publication type:
- Article
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 594, doi. 10.1093/jjco/hyaa019
- By:
- Publication type:
- Article
MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer’s Disease.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 6, p. 1800, doi. 10.3390/ijms19061800
- By:
- Publication type:
- Article
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1399, doi. 10.21873/invivo.11920
- By:
- Publication type:
- Article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 906, doi. 10.4143/crt.2016.424
- By:
- Publication type:
- Article
LAPAROSCOPIC COMMON BILE DUCT EXPLORATION.
- Published in:
- HPB Surgery, 1992, v. 5, p. 35
- By:
- Publication type:
- Article
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
- Published in:
- Amino Acids, 2014, v. 46, n. 6, p. 1527, doi. 10.1007/s00726-014-1714-2
- By:
- Publication type:
- Article
Hospital organisational health as a mediator between positive nursing organisational culture, caring behaviour, and quality of nursing care.
- Published in:
- Humanities & Social Sciences Communications, 2024, p. 1, doi. 10.1057/s41599-024-03731-w
- By:
- Publication type:
- Article
Axillary recurrence after negative sentinel lymph node biopsy.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 114, n. 2, p. 301, doi. 10.1007/s10549-008-9994-4
- By:
- Publication type:
- Article
Sentinel node biopsy in patients with multiple breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 109, n. 3, p. 503, doi. 10.1007/s10549-007-9674-9
- By:
- Publication type:
- Article
Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 15, p. 2944, doi. 10.1002/cam4.4663
- By:
- Publication type:
- Article
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
- Published in:
- FASEB Journal, 2013, v. 27, n. 9, p. 3487, doi. 10.1096/fj.12-224220
- By:
- Publication type:
- Article
Endothelial cell loss in penetrating keratoplasty, endothelial keratoplasty, and deep anterior lamellar keratoplasty.
- Published in:
- Taiwan Journal of Ophthalmology, 2017, v. 7, n. 4, p. 199, doi. 10.4103/tjo.tjo_55_17
- By:
- Publication type:
- Article
Early Detection of Post-Endarterectomy Complication by Point-of-Care Ultrasound.
- Published in:
- Reports (MDPI AG), 2021, v. 4, n. 3, p. 1, doi. 10.3390/reports4030021
- By:
- Publication type:
- Article
An increase of CD8<sup>+</sup> T cell infiltration following recurrence is a good prognosticator in HNSCC.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77036-8
- By:
- Publication type:
- Article
Regulatory (FoxP3<sup>+</sup>) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-76130-1
- By:
- Publication type:
- Article
CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 6, p. 1316, doi. 10.1002/ijc.25466
- By:
- Publication type:
- Article
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0299-6
- By:
- Publication type:
- Article
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.
- Published in:
- Familial Cancer, 2014, v. 13, n. 2, p. 205, doi. 10.1007/s10689-014-9704-9
- By:
- Publication type:
- Article
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274830
- By:
- Publication type:
- Article
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
- Published in:
- Oncology, 2022, v. 100, n. 4, p. 228, doi. 10.1159/000516813
- By:
- Publication type:
- Article
High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 16, p. 3019, doi. 10.1002/cncr.33571
- By:
- Publication type:
- Article
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16164-1
- By:
- Publication type:
- Article
Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194730
- By:
- Publication type:
- Article